http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108349943-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ca0841c52dc980c3f201762d410f79b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2016-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c53546917271bff5eb94fb21aa158365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca922d69d99e6101c0f8956b7e7061c
publicationDate 2018-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108349943-A
titleOfInvention Heterocyclic restricted tricyclic sulfonamides as anticancer agents
abstract Disclosed are arylsulfonamide derivatives of a class of heterocyclic restricted tricyclic compounds. The compounds are of the following class: (I). These compounds induce the translocation of the FOXO1 transcription factor to the nucleus by modulating PP2A and thus exhibit antiproliferative effects. It can be used to treat a variety of diseases, including as a therapy in cancer treatment, or in combination with other drugs to restore sensitivity to chemotherapy when resistance has developed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114272378-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114272378-A
priorityDate 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466581924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466736919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468067824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455176429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467083350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466468751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467442328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466448497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468116965

Total number of triples: 35.